Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MORF | AMGN | VRTX | REGN | GSK |
| Company | Morphic Holding Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 30.12 | 304.55 | 480.18 | 998.45 | 41.10 |
| High | 30.29 | 305.53 | 481.87 | 998.45 | 41.22 |
| Low | 29.22 | 301.37 | 478.51 | 992.23 | 40.96 |
| Last | 29.89 | 301.89 | 480.47 | 994.73 | 41.13 |
| Change | -0.88 | -3.13 | -2.57 | -8.22 | -0.08 |
| % Change | -2.86% | -1.03% | -0.53% | -0.82% | -0.19% |
| Volume | 71,467 | 295,713 | 155,326 | 25,786 | 336,402 |
| 20-Day Average Volume | 476,296 | 2,197,935 | 1,168,483 | 372,030 | 4,150,198 |
| Previous Close | 30.77 | 305.02 | 483.04 | 1,002.95 | 41.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.20 | 307.79 | 454.48 | 984.88 | 43.84 |
| 20-Day Raw Stochastic | 32.50% | 25.82% | 92.08% | 66.82% | 10.99% |
| 20-Day Relative Strength | 48.05% | 53.07% | 72.66% | 58.98% | 40.97% |
| Weighted Alpha | -19.69 | +28.12 | +43.90 | +28.42 | +15.42 |
| Today's Opinion | 64% Sell | 72% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 16% Sell | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 56% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.59% since 06/03/24 | -1.70% since 06/03/24 | +2.38% since 06/03/24 | +0.54% since 06/03/24 | +0.55% since 06/03/24 |
| Low | 29.48 on 06/10/24 | 302.01 on 06/10/24 | 467.37 on 06/04/24 | 986.64 on 06/04/24 | 40.94 on 06/07/24 |
| High | 33.45 on 06/06/24 | 310.92 on 06/04/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 42.44 on 06/05/24 |
| 1-Month | |||||
| %Chg | +3.25% since 05/10/24 | -2.57% since 05/10/24 | +13.85% since 05/10/24 | +2.16% since 05/10/24 | -8.80% since 05/10/24 |
| Low | 27.47 on 05/24/24 | 295.49 on 05/30/24 | 422.44 on 05/14/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 33.87 on 05/16/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -20.52% since 03/08/24 | +10.39% since 03/08/24 | +16.38% since 03/08/24 | +2.69% since 03/08/24 | -4.72% since 03/08/24 |
| Low | 26.36 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 38.36 on 03/11/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +8.76% since 12/08/23 | +12.29% since 12/08/23 | +37.47% since 12/08/23 | +18.42% since 12/08/23 | +14.37% since 12/08/23 |
| Low | 25.40 on 12/11/23 | 260.68 on 04/19/24 | 351.44 on 12/11/23 | 838.44 on 12/11/23 | 35.87 on 12/15/23 |
| High | 41.47 on 02/12/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,541,393 | 163,623,392 | 124,649,928 | 110,511,040 | 85,405,248 |
| Shares Outstanding, K | 50,094 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 520,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -152,100,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -45,290,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.49 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.91 on 04/25/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 08/01/24 | 08/01/24 | 05/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.41 | 32.24 | 26.97 | 10.28 |